Alexza Pharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
November 2018
29
About the Report
About the Report
Summary
Alexza Pharmaceuticals Inc (Alexza), a wholly owned subsidiary of Ferrer Therapeutics Inc, focuses on the research, development and commercialization of novel, proprietary products for the treatment of acute central nervous system diseases. The company develops all its products based on its own proprietary technology, Staccato system (a hand-held inhaler), which is the foundation for Adasuve (loxapine), and all other product candidates. The company's lead product Adasuve (Staccato loxapine) is indicated for the treatment of agitation associated with schizophrenia or bipolar I disorder. The company's pipeline products consist of AZ-002 (Staccato alprazolam) for acute repetitive seizures and AZ-007 (Staccato zaleplon) for insomnia. Alexza is headquartered in Mountain View, California, the US.
Alexza Pharmaceuticals Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Alexza Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Alexza Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Alexza Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Alexza Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Alexza Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 9
Alexza Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Alexza Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Alexza Pharma Amends Co-Marketing Agreement with Grupo Ferrer International for Adasuve 11
Alexza Amends Co-Marketing Agreement with Grupo Ferrer International for Adasuve 12
Licensing Agreements 13
Lee's Pharma Enters into Licensing Agreement with Alexza Pharma 13
Engage Therapeutics Enters into Licensing Agreement with Alexza Pharma 14
Equity Offering 15
Alexza Pharma Raises USD5 million in Equity Offering 15
Alexza Pharma Completes Private Placement Of Shares For USD 6.4 Million 16
Alexza Pharma Completes Private Placement Of Shares For USD 5.5 Million 17
Alexza Pharma Completes Private Placement Of Shares For USD 3 Million 19
Alexza Pharma Completes Public Offering Of Common Stock For USD 22 Million 20
Debt Offering 21
Alexza Pharma Completes Private Placement Of Notes Due 2027 For USD 45 Million 21
Asset Transactions 22
Galen Acquires US Rights to ADASUVE from Alexza Pharma 22
Acquisition 23
Grupo Ferrer Acquires Alexza Pharma 23
Alexza Pharmaceuticals Inc-Key Competitors 26
Alexza Pharmaceuticals Inc-Key Employees 27
Alexza Pharmaceuticals Inc-Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29
List of Figure
List of Figures
Alexza Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Alexza Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Alexza Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Alexza Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Alexza Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Alexza Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Alexza Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Alexza Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Alexza Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 9
List of Table
List of Tables
Alexza Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts 2
Alexza Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Alexza Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Alexza Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Alexza Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Alexza Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 9
Alexza Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Alexza Pharma Amends Co-Marketing Agreement with Grupo Ferrer International for Adasuve 11
Alexza Amends Co-Marketing Agreement with Grupo Ferrer International for Adasuve 12
Lee's Pharma Enters into Licensing Agreement with Alexza Pharma 13
Engage Therapeutics Enters into Licensing Agreement with Alexza Pharma 14
Alexza Pharma Raises USD5 million in Equity Offering 15
Alexza Pharma Completes Private Placement Of Shares For USD 6.4 Million 16
Alexza Pharma Completes Private Placement Of Shares For USD 5.5 Million 17
Alexza Pharma Completes Private Placement Of Shares For USD 3 Million 19
Alexza Pharma Completes Public Offering Of Common Stock For USD 22 Million 20
Alexza Pharma Completes Private Placement Of Notes Due 2027 For USD 45 Million 21
Galen Acquires US Rights to ADASUVE from Alexza Pharma 22
Grupo Ferrer Acquires Alexza Pharma 23
Alexza Pharmaceuticals Inc, Key Competitors 26
Alexza Pharmaceuticals Inc, Key Employees 27
Alexza Pharmaceuticals Inc, Subsidiaries 28
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.